 Mercedes Rincon
Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| p38 Mitogen-Activated Protein Kinases | 9 | 2018 | 268 | 2.300 |
Why?
| | Mitochondria | 7 | 2024 | 847 | 2.210 |
Why?
| | Glycogen Synthase Kinase 3 beta | 6 | 2025 | 67 | 1.970 |
Why?
| | STAT3 Transcription Factor | 4 | 2021 | 190 | 1.750 |
Why?
| | Interleukin-6 | 5 | 2022 | 712 | 1.620 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2024 | 840 | 1.270 |
Why?
| | Mitochondrial Proteins | 4 | 2024 | 245 | 1.100 |
Why?
| | Thymocytes | 1 | 2025 | 32 | 0.940 |
Why?
| | Molecular Chaperones | 2 | 2016 | 181 | 0.830 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2025 | 334 | 0.820 |
Why?
| | Adenosine Triphosphate | 3 | 2021 | 469 | 0.810 |
Why?
| | Phosphoserine | 2 | 2020 | 33 | 0.740 |
Why?
| | Interleukins | 2 | 2016 | 240 | 0.740 |
Why?
| | Immunotherapy, Adoptive | 1 | 2024 | 295 | 0.710 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2021 | 130 | 0.690 |
Why?
| | Cell Respiration | 4 | 2024 | 98 | 0.630 |
Why?
| | Orthomyxoviridae Infections | 2 | 2016 | 67 | 0.620 |
Why?
| | Mice | 24 | 2025 | 16574 | 0.600 |
Why?
| | HSP40 Heat-Shock Proteins | 2 | 2021 | 24 | 0.600 |
Why?
| | Mice, Inbred C57BL | 15 | 2025 | 5268 | 0.590 |
Why?
| | MAP Kinase Signaling System | 4 | 2013 | 304 | 0.590 |
Why?
| | Orthomyxoviridae | 2 | 2016 | 40 | 0.580 |
Why?
| | CD4-Positive T-Lymphocytes | 4 | 2021 | 1043 | 0.570 |
Why?
| | Animals | 30 | 2025 | 34487 | 0.550 |
Why?
| | Cell Movement | 1 | 2021 | 933 | 0.540 |
Why?
| | Lymphocytes | 2 | 2018 | 367 | 0.530 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2016 | 19 | 0.520 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2021 | 744 | 0.520 |
Why?
| | Cell Death | 1 | 2017 | 342 | 0.500 |
Why?
| | Phosphorylation | 8 | 2025 | 1681 | 0.490 |
Why?
| | B-Lymphocytes | 3 | 2016 | 812 | 0.460 |
Why?
| | Aspergillus fumigatus | 3 | 2011 | 23 | 0.450 |
Why?
| | Fear | 1 | 2017 | 325 | 0.450 |
Why?
| | Cerebral Cortex | 1 | 2017 | 422 | 0.440 |
Why?
| | Cell Differentiation | 4 | 2021 | 1896 | 0.440 |
Why?
| | Behavior, Animal | 1 | 2017 | 485 | 0.440 |
Why?
| | Mice, Knockout | 10 | 2016 | 2757 | 0.430 |
Why?
| | Electron Transport Complex I | 1 | 2013 | 38 | 0.410 |
Why?
| | beta-Glucans | 1 | 2011 | 27 | 0.370 |
Why?
| | Lymphocyte Activation | 4 | 2021 | 1096 | 0.360 |
Why?
| | Neurons | 2 | 2020 | 1445 | 0.330 |
Why?
| | Lipid Metabolism | 1 | 2013 | 491 | 0.330 |
Why?
| | Allergens | 2 | 2020 | 381 | 0.330 |
Why?
| | Gene Expression Regulation | 4 | 2018 | 2508 | 0.330 |
Why?
| | Cell Cycle | 2 | 2009 | 580 | 0.310 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2009 | 37 | 0.310 |
Why?
| | Multiple Sclerosis | 2 | 2013 | 435 | 0.300 |
Why?
| | Respiratory Mucosa | 1 | 2011 | 304 | 0.300 |
Why?
| | Cell Nucleus | 2 | 2020 | 579 | 0.290 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2008 | 79 | 0.290 |
Why?
| | Antibody Formation | 1 | 2009 | 288 | 0.280 |
Why?
| | Epithelial Cells | 2 | 2022 | 1037 | 0.270 |
Why?
| | Th17 Cells | 2 | 2020 | 81 | 0.250 |
Why?
| | Mice, SCID | 2 | 2021 | 350 | 0.250 |
Why?
| | Cell Line, Tumor | 2 | 2024 | 3168 | 0.240 |
Why?
| | V(D)J Recombination | 1 | 2025 | 7 | 0.240 |
Why?
| | Cells, Cultured | 7 | 2020 | 4006 | 0.240 |
Why?
| | Ovalbumin | 1 | 2024 | 176 | 0.220 |
Why?
| | Melanoma, Experimental | 1 | 2024 | 108 | 0.210 |
Why?
| | Cytokines | 4 | 2021 | 1984 | 0.210 |
Why?
| | Asthma | 2 | 2020 | 2212 | 0.210 |
Why?
| | Disease Models, Animal | 1 | 2013 | 3936 | 0.210 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 3 | 2013 | 59 | 0.210 |
Why?
| | Calcium | 2 | 2021 | 1182 | 0.200 |
Why?
| | In Vitro Techniques | 2 | 2021 | 1047 | 0.190 |
Why?
| | Protein Kinase Inhibitors | 1 | 2008 | 875 | 0.190 |
Why?
| | Drug Resistance, Multiple | 1 | 2021 | 22 | 0.180 |
Why?
| | Signal Transduction | 4 | 2021 | 4812 | 0.170 |
Why?
| | Biomimetic Materials | 1 | 2021 | 70 | 0.170 |
Why?
| | Neutrophils | 2 | 2020 | 1192 | 0.170 |
Why?
| | Sonication | 1 | 2019 | 13 | 0.170 |
Why?
| | Doxorubicin | 1 | 2021 | 322 | 0.160 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 586 | 0.160 |
Why?
| | Interferon-gamma | 2 | 2016 | 760 | 0.160 |
Why?
| | Immunoglobulin G | 2 | 2016 | 842 | 0.150 |
Why?
| | Pulmonary Fibrosis | 1 | 2022 | 377 | 0.150 |
Why?
| | Oxygen Consumption | 1 | 2021 | 669 | 0.150 |
Why?
| | Septal Nuclei | 1 | 2018 | 19 | 0.140 |
Why?
| | RNA, Small Interfering | 1 | 2019 | 569 | 0.140 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 518 | 0.130 |
Why?
| | Immunoglobulin Class Switching | 1 | 2016 | 18 | 0.130 |
Why?
| | Female | 7 | 2024 | 68016 | 0.130 |
Why?
| | Humans | 13 | 2024 | 128019 | 0.130 |
Why?
| | Lymphocyte Subsets | 1 | 2016 | 85 | 0.130 |
Why?
| | Oxidative Phosphorylation | 1 | 2016 | 184 | 0.120 |
Why?
| | Lung | 6 | 2022 | 3745 | 0.120 |
Why?
| | Immunologic Memory | 1 | 2016 | 341 | 0.110 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2009 | 699 | 0.110 |
Why?
| | Brain | 2 | 2020 | 2615 | 0.110 |
Why?
| | Mice, Transgenic | 5 | 2011 | 2066 | 0.110 |
Why?
| | Rotenone | 1 | 2013 | 10 | 0.110 |
Why?
| | Models, Immunological | 1 | 2013 | 93 | 0.100 |
Why?
| | Reactive Oxygen Species | 1 | 2016 | 582 | 0.100 |
Why?
| | Metabolome | 1 | 2016 | 319 | 0.100 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2013 | 67 | 0.100 |
Why?
| | Intracellular Membranes | 1 | 2013 | 82 | 0.100 |
Why?
| | Eosinophils | 2 | 2020 | 323 | 0.100 |
Why?
| | Histones | 1 | 2018 | 585 | 0.100 |
Why?
| | Hippocampus | 1 | 2017 | 801 | 0.100 |
Why?
| | Antigens, Fungal | 2 | 2009 | 27 | 0.100 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2011 | 27 | 0.090 |
Why?
| | Protein Modification, Translational | 1 | 2011 | 1 | 0.090 |
Why?
| | T-Lymphocytes | 1 | 2019 | 1921 | 0.090 |
Why?
| | Serine | 2 | 2010 | 135 | 0.090 |
Why?
| | Cholesterol | 1 | 2013 | 406 | 0.090 |
Why?
| | Interleukin-17 | 1 | 2011 | 106 | 0.090 |
Why?
| | Fatty Liver | 1 | 2013 | 231 | 0.090 |
Why?
| | Natural Killer T-Cells | 1 | 2011 | 65 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2013 | 495 | 0.090 |
Why?
| | Antineoplastic Agents | 1 | 2021 | 2041 | 0.080 |
Why?
| | Repressor Proteins | 1 | 2013 | 399 | 0.080 |
Why?
| | X-Rays | 1 | 2009 | 27 | 0.080 |
Why?
| | Stress, Psychological | 1 | 2018 | 1060 | 0.080 |
Why?
| | Male | 6 | 2021 | 62757 | 0.080 |
Why?
| | Cell Extracts | 1 | 2009 | 17 | 0.080 |
Why?
| | Receptors, Interleukin-21 | 1 | 2009 | 1 | 0.080 |
Why?
| | Interleukin-6 Receptor alpha Subunit | 1 | 2009 | 1 | 0.080 |
Why?
| | Th2 Cells | 2 | 2009 | 167 | 0.080 |
Why?
| | Metaplasia | 1 | 2009 | 54 | 0.080 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2010 | 181 | 0.080 |
Why?
| | Cell Survival | 2 | 2010 | 1073 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 228 | 0.080 |
Why?
| | Catalytic Domain | 1 | 2009 | 217 | 0.070 |
Why?
| | Recombination, Genetic | 1 | 2009 | 189 | 0.070 |
Why?
| | Mice, Inbred Strains | 1 | 2009 | 402 | 0.070 |
Why?
| | Receptors, Histamine H1 | 1 | 2007 | 4 | 0.070 |
Why?
| | DNA Repair | 1 | 2009 | 205 | 0.070 |
Why?
| | Immunoglobulin M | 1 | 2009 | 272 | 0.070 |
Why?
| | Thymus Gland | 1 | 2008 | 309 | 0.070 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2010 | 391 | 0.070 |
Why?
| | Inflammation | 4 | 2020 | 2646 | 0.070 |
Why?
| | Neoplasms | 1 | 2021 | 2460 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 815 | 0.070 |
Why?
| | beta Catenin | 1 | 2008 | 217 | 0.060 |
Why?
| | Proto-Oncogene Proteins | 1 | 2010 | 632 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2008 | 419 | 0.060 |
Why?
| | Hypersensitivity | 1 | 2009 | 249 | 0.060 |
Why?
| | Autoimmunity | 1 | 2011 | 860 | 0.060 |
Why?
| | Diet | 1 | 2013 | 1198 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 179 | 0.060 |
Why?
| | Interleukin-13 | 1 | 2005 | 144 | 0.060 |
Why?
| | Antibodies, Viral | 1 | 2009 | 601 | 0.060 |
Why?
| | Bone Marrow Cells | 1 | 2005 | 293 | 0.060 |
Why?
| | Lipopolysaccharides | 2 | 2022 | 854 | 0.050 |
Why?
| | Gene Expression | 1 | 2009 | 1454 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2010 | 1105 | 0.050 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2006 | 312 | 0.050 |
Why?
| | Membrane Glycoproteins | 1 | 2005 | 467 | 0.050 |
Why?
| | Bacteria | 1 | 2009 | 812 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2019 | 1140 | 0.050 |
Why?
| | Models, Biological | 1 | 2008 | 1689 | 0.050 |
Why?
| | Epithelium | 1 | 2022 | 306 | 0.050 |
Why?
| | NF-kappa B | 1 | 2005 | 649 | 0.050 |
Why?
| | Apoptosis | 1 | 2010 | 2425 | 0.040 |
Why?
| | Respiratory Hypersensitivity | 1 | 2020 | 64 | 0.040 |
Why?
| | Neural Stem Cells | 1 | 2020 | 141 | 0.040 |
Why?
| | Astrocytes | 1 | 2020 | 188 | 0.040 |
Why?
| | Microglia | 1 | 2020 | 228 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2020 | 801 | 0.040 |
Why?
| | DNA Damage | 1 | 2020 | 363 | 0.040 |
Why?
| | Models, Animal | 1 | 2019 | 365 | 0.040 |
Why?
| | Th1 Cells | 2 | 2009 | 136 | 0.040 |
Why?
| | Enzyme Activation | 2 | 2011 | 796 | 0.040 |
Why?
| | Reflex, Startle | 1 | 2018 | 67 | 0.040 |
Why?
| | Blotting, Western | 1 | 2019 | 1169 | 0.030 |
Why?
| | Homeostasis | 2 | 2010 | 605 | 0.030 |
Why?
| | Weight Gain | 1 | 2018 | 503 | 0.030 |
Why?
| | MAP Kinase Kinase 3 | 1 | 2011 | 7 | 0.020 |
Why?
| | MAP Kinase Kinase 6 | 1 | 2011 | 3 | 0.020 |
Why?
| | Anxiety | 1 | 2018 | 951 | 0.020 |
Why?
| | Aging | 1 | 2020 | 1745 | 0.020 |
Why?
| | Cell Separation | 1 | 2011 | 312 | 0.020 |
Why?
| | Hydrocolpos | 1 | 2010 | 6 | 0.020 |
Why?
| | Limb Deformities, Congenital | 1 | 2010 | 12 | 0.020 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2010 | 38 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 160 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2010 | 292 | 0.020 |
Why?
| | Candida albicans | 1 | 2009 | 54 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1020 | 0.020 |
Why?
| | Mucus | 1 | 2009 | 75 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2009 | 95 | 0.020 |
Why?
| | Liver Diseases | 1 | 2011 | 285 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2011 | 1227 | 0.020 |
Why?
| | Orchitis | 1 | 2007 | 4 | 0.020 |
Why?
| | Vagina | 1 | 2010 | 175 | 0.020 |
Why?
| | Histamine | 1 | 2007 | 65 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 6479 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2009 | 263 | 0.020 |
Why?
| | Immunologic Factors | 1 | 2009 | 227 | 0.020 |
Why?
| | Pseudomonas aeruginosa | 1 | 2009 | 344 | 0.020 |
Why?
| | STAT6 Transcription Factor | 1 | 2005 | 24 | 0.020 |
Why?
| | Immunity | 1 | 2006 | 132 | 0.020 |
Why?
| | Pre-B Cell Receptors | 1 | 2005 | 1 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-rel | 1 | 2005 | 7 | 0.020 |
Why?
| | Chronic Disease | 1 | 2011 | 1690 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 147 | 0.020 |
Why?
| | Leukocyte Common Antigens | 1 | 2005 | 81 | 0.010 |
Why?
| | Matrix Metalloproteinases | 1 | 2005 | 89 | 0.010 |
Why?
| | Retroviridae | 1 | 2005 | 97 | 0.010 |
Why?
| | Luciferases | 1 | 2005 | 147 | 0.010 |
Why?
| | Chemokines | 1 | 2005 | 221 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2011 | 1354 | 0.010 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2005 | 126 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2005 | 265 | 0.010 |
Why?
| | Gene Transfer Techniques | 1 | 2005 | 162 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2011 | 2337 | 0.010 |
Why?
| | Green Fluorescent Proteins | 1 | 2005 | 380 | 0.010 |
Why?
| | Antibodies | 1 | 2005 | 392 | 0.010 |
Why?
| | Cell Line | 1 | 2007 | 2736 | 0.010 |
Why?
| | Mutation | 1 | 2010 | 3682 | 0.010 |
Why?
|
|
Rincon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|